Literature DB >> 1675941

Comprehensive analysis of perfusion scintigraphy in Takayasu's arteritis.

I Umehara1, H Shibuya, T Nakagawa, F Numano.   

Abstract

One hundred eighty perfusion lung scans of 120 patients with Takayasu's arteritis were retrospectively evaluated. Lung scans were abnormal in 76% of the patients. Lung scans could be classified into four groups, according to the pattern of perfusion defects. Early involvement occurred in the upper lobes, and the middle and lower lobes were involved at a later stage. The data obtained by physiological examination (spirography and arterial blood gas analysis) showed a weak relationship with the severity of perfusion lung scan findings. In addition, repeated lung scans were found to be easy and reliable in the follow-up period of pulmonary artery involvement.

Entities:  

Mesh:

Year:  1991        PMID: 1675941     DOI: 10.1097/00003072-199105000-00012

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  4 in total

1.  Clinical and radiographic features mimicking pulmonary embolism as the first manifestation of Takayasu's arteritis.

Authors:  Amir Shlomai; Alon Y Hershko; Ezra Gabbay; Eldad Ben-Chetrit
Journal:  Clin Rheumatol       Date:  2004-07-02       Impact factor: 2.980

2.  Radionuclide imaging in Takayasu's arteritis: two case presentations.

Authors:  S Namwongprom; R Kanjanavanit; M Ekmahachai; S Boonyaprapa
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

Review 3.  Pulmonary vasculitis: classification, clinical features, and management.

Authors:  A Ciaccia; M Ferrari; F M Facchini; G Caramori; L Fabbri
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

4.  Pulmonary arterial lesions in Takayasu arteritis: relationship of inflammatory activity to scintigraphic findings and sequential changes.

Authors:  Y Ogawa; K Hayashi; I Sakamoto; N Matsunaga
Journal:  Ann Nucl Med       Date:  1996-05       Impact factor: 2.668

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.